Literature DB >> 884934

Effect of warfarin on the metabolism of phylloquinone (vitamin K1):dose-response relationships in man.

M J Shearer, A McBurney, A M Breckenridge, P Barkhan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884934     DOI: 10.1042/cs0520621

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


× No keyword cloud information.
  13 in total

1.  Alteration of hemostasis associated with cefoperazone treatment.

Authors:  K Andrassy; J Koderisch; S Fritz; H Bechtold; H Sonntag
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

2.  The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.

Authors:  I A Choonara; R G Malia; B P Haynes; C R Hay; S Cholerton; A M Breckenridge; F E Preston; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

3.  Enantiomers of warfarin and vitamin K1 metabolism.

Authors:  I A Choonara; B P Haynes; S Cholerton; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

4.  Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins.

Authors:  B K Park; I A Choonara; B P Haynes; A M Breckenridge; R G Malia; F E Preston
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

5.  Vitamin K prodrugs: 2. water-soluble prodrugs of menahydroquinone-4 for systemic site-specific delivery.

Authors:  J Takata; Y Karube; M Hanada; K Matsunaga; Y Matsushima; T Sendo; R Oishi
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

6.  Cyclic interconversion of vitamin K1 and vitamin K1 2,3-epoxide in man.

Authors:  H Bechtold; D Trenk; T Meinertz; M Rowland; E Jähnchen
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

7.  Stereoselective interaction between the R enantiomer of warfarin and cimetidine.

Authors:  I A Choonara; S Cholerton; B P Haynes; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

8.  Enzyme induction by phenobarbitone and vitamin K1 disposition in man.

Authors:  B K Park; A C Wilson; G Kaatz; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

9.  Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients.

Authors:  I A Choonara; A K Scott; B P Haynes; S Cholerton; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

10.  Mechanisms of action of the anticoagulants warfarin, 2-chloro-3-phytylnaphthoquinone (Cl-K), acenocoumarol, brodifacoum and difenacoum in the rabbit [proceedings].

Authors:  A M Breckenridge; J B Leck; B K Park; M J Serlin; A Wilson
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.